Bills · S 1407
IN COMMITTEE· 119TH CONGRESS
Senate BillS 1407Health
ABC Safe Drug Act
INTRO APR 10· LAST ACTION APR 10
READING
3MIN
COSPONSORS
0
READER REACTIONS0 TOTAL
NO VOTES YET · BE THE FIRST
- Introduced only
LEGISLATIVE PROGRESS
STEP 2 / 8Introduced
In Committee
Reported
Passed Senate
Passed House
Conference
To President
Became Law
WHAT THE BILL DOES
AI-writtenVoters should care about this bill because it directly addresses concerns about the reliability and security of the nation's drug supply. If this bill becomes law, it aims to reduce America's dependence on foreign countries, specifically China, for essential drug ingredients. This could make the drug supply less vulnerable to geopolitical tensions, trade disputes, or quality control issues in other nations, potentially preventing drug shortages during crises.
However, if it doesn't become law, the current reliance on Chinese-made active pharmaceutical ingredients would likely continue, leaving the U.S. drug supply exposed to the same vulnerabilities. The bill also impacts American jobs and economic activity by offering incentives for pharmaceutical and medical device manufacturing to return to or expand within the U.S. This could create new opportunities but might also lead to higher drug costs for federal programs, which could then indirectly affect taxpayers or program beneficiaries. The transparency requirement for ingredient origin could also empower consumers with more information about their medications.
KEY PROVISIONS
4AI-extractedPROVISION 01
Federal health programs must gradually reduce and then eliminate purchases of drugs with active ingredients from China, starting with 60% by January 1, 2028, and 100% by January 1, 2030.
This aims to secure the U.S. drug supply chain and reduce reliance on China for essential medicines.
PROVISION 02
The Secretary of Health and Human Services can issue waivers to these purchasing restrictions, but no waivers will be allowed after January 1, 2031.
This provides flexibility for federal programs to avoid immediate drug shortages while transitioning away from Chinese-sourced ingredients.
PROVISION 03
Drug labels must include the country of origin for each active ingredient contained in the drug.
This provides greater transparency for consumers and healthcare providers about where drug components are manufactured.
PROVISION 04
Businesses can immediately write off 100% of the cost of new property used for drug and medical device manufacturing in the U.S., for property placed in service between 2025 and 2030.
This tax incentive is designed to encourage and accelerate domestic manufacturing of pharmaceuticals and medical devices.
SPONSORSHIP
1 + 0
R· Arkansas
YRS IN OFFICE
13
BILLS LED
97
ACTION TIMELINE
2 EVENTSAPR 10
Introduced in Senate
APR 10
Read twice and referred to the Committee on Finance.
BILL INFO
TypeSenate Bill
NumberS 1407
Congress119th
StatusIn Committee
IntroducedApr 10, 2025
Last actionApr 10, 2025
READER REACTIONS
OVERALL SENTIMENT
No reactions yet. Be the first to weigh in.
Discussion
Loading comments...
IN COMMITTEE· 119TH CONGRESS · FINANCE COMMITTEE · INTRODUCED APR 10, 2025
Senate BillS 1407Health
ABC Safe Drug Act
INTRODUCED APR 10, 2025· LAST ACTION APR 10, 2025
PASSAGE CHANCES
—%
READING
3 min
COSPONSORS
0
COMPLEXITY
Moderate
